The Novel HLA‐DRB1*13:348 Allele Characterised by Two Different Sequencing‐Based Typing Techniques
HLA · 2025
DOI: 10.1111/tan.70102 ↗At a glance
Journal article in HLA, 2025. Written by Adèle Dhuyser and 4 co-authors. Institution: HLA and Histocompatibility Laboratory, CHRU de Nancy, Vandœuvre-lès-Nancy, France. Major MEDLINE topics: HLA-DRB1 Chains, Alleles, Histocompatibility Testing, Exons. Cited 2 times so far (Crossref); 4 references.
Abstract (original language)
The novel allele HLA‐DRB1*13:348 differs from HLA‐DRB1*13:02:01:01 by one non‐synonymous nucleotide substitution in exon 2.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- HLA and Histocompatibility Laboratory, CHRU de Nancy, Vandœuvre-lès-Nancy, France.
- IMoPA, UMR7365 CNRS, Université de Lorraine, Vandœuvre-lès-Nancy, France.
ORCID profiles: Adèle Dhuyser
Cite
APA
Dhuyser, A., Pérès, M., Morel, T., Clément, S., & Aarnink, A. (2025). The Novel HLA‐DRB1*13:348 Allele Characterised by Two Different Sequencing‐Based Typing Techniques. HLA. https://doi.org/10.1111/tan.70102
Vancouver
Dhuyser A, Pérès M, Morel T, Clément S, Aarnink A. The Novel HLA‐DRB1*13:348 Allele Characterised by Two Different Sequencing‐Based Typing Techniques. HLA. 2025. doi:10.1111/tan.70102
BibTeX
@article{Dhuyser2025,
author = {Dhuyser, Adèle and Pérès, Michaël and Morel, Thomas and Clément, Sandra and Aarnink, Alice},
title = {The Novel HLA‐DRB1*13:348 Allele Characterised by Two Different Sequencing‐Based Typing Techniques},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70102}
}
EUVIMED